Former Tilray CEO Joins Psychedelics Company
More big names in cannabis are switching to psychedelics.
Analysis: Aurora Cannabis Could Improve Position Based On Exports, Jushi Price Target Adjusted Down
Cantor Fitzgerald released two reports ahead of featured chats with the CEOs of Aurora Cannabis (NASDAQ: ACB) (TSX: ACB) and Jushi Holdings (CSE: JUSH) (OTCQX: JUSHF).
Curaleaf Buys One Of Colorado’s Largest Cannabis Farms In $67M Deal
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has completed the acquisition of Los Sueños Farms, a large-scale outdoor cannabis grow in Colorado.
Breaking: Canopy Growth Provides CBD For New Product Out Of Constellation Brands’ Portfolio
Karma Water, a company with a portfolio of wellness and probiotic water beverages, has partnered with Canopy Growth Corporation (NYSE: CGC) to develop and launch a brand of CBD beverages called Karma CBD Water.
CanaFarma To Spend $2 Million On A New Subsidiary Ahead Of Merger With Vertical Wellness
CanaFarma Hemp Products Corp. (CSE: CNFA) has signed a letter of intent to acquire Avitas Bio Corp., a company with a portfolio of consumer products, which includes nutraceuticals and hemp-derived CBD edibles and topicals.
New Study Suggests Ketamine Could Work Better Without Additional Antidepressants
Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF) released results of a clinical study suggesting that ketamine could be as effective on its own in the treatment of depression as it is in combination with traditional antidepressants.
4 Stocks Disrupting Mental Health To Keep An Eye On At Benzinga’s Healthcare Conference
The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth.
Elon Musk Acknowledges Therapeutic Potential Of Psychedelic Drugs: Will This Impact The Markets?
Elon Musk expressed his support for the therapeutic potential of psychedelic drugs.
The Space X and Tesla (NASDAQ: TSLA) CEO shared his opinion on psychedelic substances in a Q&A at the CodeCon event on Tuesday.
Can MDMA (Or Ecstasy) Improve Sexual Desire in Women? MindCure Launches Research Program To Find Out
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF), a company in the psychedelics space, is looking to bring current advancements in MDMA therapy to women’s sexual dysfunction.